SARS_Cov2

Research

Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study

Date: October 9, 2020 Source 1: KU Leuven Source 2: www.sciencedaily.com Summary: Virologists have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by contrast, has an antiviral effect in the hamsters. Virologists from the KU Leuven Rega Institute […]

Research

Immune response to Sars-Cov-2 following organ transplantation

Date: August 17, 2020 Source 1: Ruhr-University Bochum Source 2: www.sciencedaily.com Summary: Even patients with suppressed immune systems can achieve a strong immune response to Sars-Cov-2. A test helps to adapt therapy following an infection. A research team from the University Hospital at Ruhr-Universität Bochum (RUB) has developed a test that provides information on the

Scroll to Top